SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
74 hedge funds and large institutions have $94.3M invested in Strongbridge Biopharma plc. in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+3
Holders Change %
+4.23%
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
25
Reduced
25
Closed
7
Calls
$527K
Puts
$252K
Net Calls
+$275K
Net Calls Change
+$235K
Top Buyers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.19M |
| 2 |
Morgan Stanley
New York
|
+$1.04M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$1.03M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$719K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$538K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$4.82M |
| 2 |
6CM
683 Capital Management
New York
|
-$3.88M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$3.53M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.5M |
| 5 |
Renaissance Technologies
New York
|
-$1.77M |
